Inolife engages Maxim Group for IB services

Inolife Technologies (OTC:INOL) has signed an agreement with Maxim Group to provide strategic corporate planning and investment banking services.

Among other things, Maxim Group will assist Inolife to become fully reporting under SEC guidelines, with the goal of completing an uplisting to the NASDAQ Capital Market within the next 12 months.

Maxim's efforts will be led by Jim Alfaro, managing director of the firm's healthcare investment banking division.

"This is a very important milestone for Inolife on our path to graduating to a national stock exchange," Michael Wright, president and CEO of Inolife, said in a statement, adding that "we are confident that they are the right corporate finance partner for Inolife."